{"success":true,"data":{"pressRelease":{"id":"72041","rtpr_id":"nPn1v5Rmna","ticker":"INMD","exchange":"NASDAQ","all_tickers":["INMD"],"title":"InMode Confirms Receipt of Unsolicited Proposal","author":"PR Newswire","published_at":"2026-06-24T12:41:01.288Z","article_body":"InMode Confirms Receipt of Unsolicited Proposal\n\nPR Newswire\n\nYOKNEAM, Israel, June 24, 2026\n\nYOKNEAM, Israel, June 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) (the\n\"Company\") today announced that, on June 17, 2026, its Board of Directors (the\n\"Board\") received an unsolicited  proposal from M.N. Business Strategy, Ltd.\n(\"MN Business Strategy\") to acquire through a merger all of the outstanding\nordinary shares of the Company not already owned by MN Business Strategy and\nits affiliates for $16.20 per share in cash (the \"Proposal\").  MN Business\nStrategy is a group that includes, among others, Moshe Mizrahy, the Company's\nco-founder and Chief Executive Officer.\n\nThe Board has approved formation of a special committee comprised solely of\nindependent directors to evaluate the Proposal.  The special committee will,\nin consultation with its advisors, evaluate the Proposal in accordance with\nits fiduciary duties and the best interests of the Company and all of its\nshareholders.  There can be no assurance as to whether this evaluation will\nresult in a transaction or any other strategic outcome for the Company, or as\nto the timing or terms of any such transaction or outcome. The Company does\nnot intend to comment further on the special committee process or provide\nadditional updates unless and until required to do so under applicable law or\nregulation.\n\nAbout InMode Ltd.\n\nThe Company is a leading global provider of innovative medical technologies.\nThe Company develops, manufactures and markets devices harnessing novel\nradiofrequency (\"RF\") technology.  The Company strives to enable new emerging\nsurgical procedures as well as improve existing treatments.  The Company has\nleveraged its medically accepted minimally invasive RF technologies to offer a\ncomprehensive line of products across several categories for plastic surgery,\ngynecology, dermatology, otolaryngology and ophthalmology.  For more\ninformation about the Company and its wide array of medical technologies,\nvisit www.inmodemd.com (https://www.inmodemd.com/) .\n\nForward-Looking Statements\n\nThis press release contains \"forward-looking statements\" within the meaning of\nthe Private Securities Litigation Reform Act of 1995.  Forward-looking\nstatements include all statements that are not historical facts.  In some\ncases, forward-looking statements can be identified by terms such as\n\"anticipate,\" \"believe,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\"\n\"plan,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"will,\" \"would\" or the\nnegative of those terms or other comparable terminology.  Forward-looking\nstatements in this press release include, but are not limited to, statements\nregarding the Proposal, the special committee's review and evaluation of the\nProposal, the potential consummation of any transaction and the Company's\nfuture plans, objectives, expectations and intentions.  These statements\ninvolve known and unknown risks, uncertainties, and other factors that may\ncause the Company's actual results, performance or achievements to be\nmaterially different from those expressed or implied.  Such factors include,\namong others: uncertainties as to whether the special committee will determine\nthat the Proposal or any alternative transaction is in the best interests of\nthe Company and its shareholders; the risk that the Proposal may be withdrawn\nor modified; the possibility that competing offers or alternatives may or may\nnot emerge; the risk that any transaction may not be consummated on the terms\nor timeline currently contemplated, or at all; and the other risks described\nin the Company's filings with the U.S. Securities and Exchange Commission.\n The Company undertakes no obligation to update any forward-looking\nstatement, whether as a result of new information, future events or otherwise\nexcept as required by law.\n\nContacts\n\nMiri Segal-Scharia\nMS-IR LLC\nir@inmodemd.com (mailto:ir@inmodemd.com)\n\nLogo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg\n(https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/inmode-confirms-receipt-of-unsolicited-proposal-302809269.html\n(https://www.prnewswire.com/news-releases/inmode-confirms-receipt-of-unsolicited-proposal-302809269.html)\n\nSOURCE InMode LTD\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/1064477/InMode_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn1v5Rmna","title":"InMode Confirms Receipt of Unsolicited Proposal","author":"PR Newswire","ticker":"INMD","created":"2026-06-24T12:41:01.288Z","tickers":["INMD"],"exchange":"NASDAQ","article_body":"InMode Confirms Receipt of Unsolicited Proposal\n\nPR Newswire\n\nYOKNEAM, Israel, June 24, 2026\n\nYOKNEAM, Israel, June 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) (the\n\"Company\") today announced that, on June 17, 2026, its Board of Directors (the\n\"Board\") received an unsolicited  proposal from M.N. Business Strategy, Ltd.\n(\"MN Business Strategy\") to acquire through a merger all of the outstanding\nordinary shares of the Company not already owned by MN Business Strategy and\nits affiliates for $16.20 per share in cash (the \"Proposal\").  MN Business\nStrategy is a group that includes, among others, Moshe Mizrahy, the Company's\nco-founder and Chief Executive Officer.\n\nThe Board has approved formation of a special committee comprised solely of\nindependent directors to evaluate the Proposal.  The special committee will,\nin consultation with its advisors, evaluate the Proposal in accordance with\nits fiduciary duties and the best interests of the Company and all of its\nshareholders.  There can be no assurance as to whether this evaluation will\nresult in a transaction or any other strategic outcome for the Company, or as\nto the timing or terms of any such transaction or outcome. The Company does\nnot intend to comment further on the special committee process or provide\nadditional updates unless and until required to do so under applicable law or\nregulation.\n\nAbout InMode Ltd.\n\nThe Company is a leading global provider of innovative medical technologies.\nThe Company develops, manufactures and markets devices harnessing novel\nradiofrequency (\"RF\") technology.  The Company strives to enable new emerging\nsurgical procedures as well as improve existing treatments.  The Company has\nleveraged its medically accepted minimally invasive RF technologies to offer a\ncomprehensive line of products across several categories for plastic surgery,\ngynecology, dermatology, otolaryngology and ophthalmology.  For more\ninformation about the Company and its wide array of medical technologies,\nvisit www.inmodemd.com (https://www.inmodemd.com/) .\n\nForward-Looking Statements\n\nThis press release contains \"forward-looking statements\" within the meaning of\nthe Private Securities Litigation Reform Act of 1995.  Forward-looking\nstatements include all statements that are not historical facts.  In some\ncases, forward-looking statements can be identified by terms such as\n\"anticipate,\" \"believe,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\"\n\"plan,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"will,\" \"would\" or the\nnegative of those terms or other comparable terminology.  Forward-looking\nstatements in this press release include, but are not limited to, statements\nregarding the Proposal, the special committee's review and evaluation of the\nProposal, the potential consummation of any transaction and the Company's\nfuture plans, objectives, expectations and intentions.  These statements\ninvolve known and unknown risks, uncertainties, and other factors that may\ncause the Company's actual results, performance or achievements to be\nmaterially different from those expressed or implied.  Such factors include,\namong others: uncertainties as to whether the special committee will determine\nthat the Proposal or any alternative transaction is in the best interests of\nthe Company and its shareholders; the risk that the Proposal may be withdrawn\nor modified; the possibility that competing offers or alternatives may or may\nnot emerge; the risk that any transaction may not be consummated on the terms\nor timeline currently contemplated, or at all; and the other risks described\nin the Company's filings with the U.S. Securities and Exchange Commission.\n The Company undertakes no obligation to update any forward-looking\nstatement, whether as a result of new information, future events or otherwise\nexcept as required by law.\n\nContacts\n\nMiri Segal-Scharia\nMS-IR LLC\nir@inmodemd.com (mailto:ir@inmodemd.com)\n\nLogo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg\n(https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/inmode-confirms-receipt-of-unsolicited-proposal-302809269.html\n(https://www.prnewswire.com/news-releases/inmode-confirms-receipt-of-unsolicited-proposal-302809269.html)\n\nSOURCE InMode LTD\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/1064477/InMode_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-06-24T12:41:01.337181398Z","server_sent_at_ms":1782304861337},"received_at":"2026-06-24T12:41:01.405Z","source_url":"https://www.prnewswire.com/news-releases/inmode-confirms-receipt-of-unsolicited-proposal-302809269.html"},"analysis":{"id":"61417","press_release_id":"72041","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":["Proposal submitted by a group including the CEO and co-founder, creating a potential conflict of interest (related-party transaction)"],"eventType":"m_and_a","narrative":"InMode confirmed receipt of an unsolicited proposal from M.N. Business Strategy, a group led by CEO and co-founder Moshe Mizrahy, to acquire all outstanding shares for $16.20 per share in cash.\n\nThe Board of Directors has formed a special committee of independent directors to evaluate the proposal with the assistance of legal and financial advisors.\n\nThe company emphasized that there is no assurance the evaluation will result in a transaction or that any deal will be consummated on the proposed terms.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"CEO-led group makes unsolicited $16.20 cash bid; special committee formed to evaluate potential take-private."},"keyFigures":{"offeringPrice":16.2},"quotedText":"","namedEntities":{"people":[{"name":"Moshe Mizrahy","role":"Co-founder and Chief Executive Officer"}],"products":[],"companies":[{"name":"M.N. Business Strategy, Ltd.","relationship":"bidder"},{"name":"InMode Ltd.","ticker":"INMD"}],"dollarAmounts":[{"amount":"$16.20 per share","context":"unsolicited cash offer to acquire outstanding shares"}]},"materialImpact":{"score":5,"reasoning":"Unsolicited proposal to acquire all outstanding shares for cash, representing a potential change of control event and a significant premium to the trading price (implied by the bid)."},"tickerRelevance":{"others":[],"primary":"INMD"},"globalImportance":45,"audienceRelevance":40,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"unsolicited M&A proposal","sectorWeight":"medical devices"}},"event_type":"m_and_a","event_type_secondary":null,"sentiment":"bullish","material_impact_score":5,"narrative":"InMode confirmed receipt of an unsolicited proposal from M.N. Business Strategy, a group led by CEO and co-founder Moshe Mizrahy, to acquire all outstanding shares for $16.20 per share in cash.\n\nThe Board of Directors has formed a special committee of independent directors to evaluate the proposal with the assistance of legal and financial advisors.\n\nThe company emphasized that there is no assurance the evaluation will result in a transaction or that any deal will be consummated on the proposed terms.","key_figures":{"offeringPrice":16.2},"named_entities":{"people":[{"name":"Moshe Mizrahy","role":"Co-founder and Chief Executive Officer"}],"products":[],"companies":[{"name":"M.N. Business Strategy, Ltd.","relationship":"bidder"},{"name":"InMode Ltd.","ticker":"INMD"}],"dollarAmounts":[{"amount":"$16.20 per share","context":"unsolicited cash offer to acquire outstanding shares"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-24T13:08:05.257Z","global_importance":45,"audience_relevance":40,"importance_components":{"tickerTier":"mid-cap","eventGravity":"unsolicited M&A proposal","sectorWeight":"medical devices"}},"durationMs":126046,"modelName":"george-droid-qwen-72b"}}